Clinical manifestations of exacerbations of cystic fibrosis associated with nonbacterial infections
- PMID: 2380817
- PMCID: PMC7130847
- DOI: 10.1016/s0022-3476(05)80530-x
Clinical manifestations of exacerbations of cystic fibrosis associated with nonbacterial infections
Abstract
The purpose of this study was to determine whether acute pulmonary exacerbations of cystic fibrosis associated with nonbacterial infections are clinically distinguishable from other exacerbations. Eighty exacerbations in 54 patients were studied. Exacerbations associated with influenza (n = 8) were compared with those associated with other nonbacterial infections (n = 15) and those in which no nonbacterial infection was detected (n = 57). Patients with influenza had lower Shwachman scores and were more likely to be seropositive for C-reactive protein than patients in the other two groups. Patients with influenza had a mean decrease in forced expiratory volume per second of 26%, compared with test results obtained before the exacerbation. In contrast, the mean decrease in forced expiratory volume per second was 6% for other nonbacterial infections and 12% for the group without nonbacterial infection (p less than 0.05 for both comparisons). The forced expiratory flow in first 25% of vital capacity decreased 44% in the influenza group compared with 13% and 17% in the other two groups, respectively (p less than 0.01 for both comparisons). The influenza group also had a higher proportion of patients with at least a 20% decrease in forced expiratory volume per second and forced expiratory flow in first 25% of vital capacity than the other two groups had (p less than 0.05 for all comparisons). These data suggest that influenza is associated with severe exacerbations in patients with cystic fibrosis and support recommendations for efforts to prevent influenza in this population.
Similar articles
-
Effect of respiratory virus infections including rhinovirus on clinical status in cystic fibrosis.Arch Dis Child. 1995 Aug;73(2):117-20. doi: 10.1136/adc.73.2.117. Arch Dis Child. 1995. PMID: 7574853 Free PMC article.
-
Intravenous immune globulin treatment of pulmonary exacerbations in cystic fibrosis.J Pediatr. 1989 Feb;114(2):309-14. doi: 10.1016/s0022-3476(89)80804-2. J Pediatr. 1989. PMID: 2915293 Clinical Trial.
-
Association of respiratory viral infections with pulmonary deterioration in patients with cystic fibrosis.N Engl J Med. 1984 Dec 27;311(26):1653-8. doi: 10.1056/NEJM198412273112602. N Engl J Med. 1984. PMID: 6504106
-
Oxidative stress during acute respiratory exacerbations in cystic fibrosis.Thorax. 1999 Jun;54(6):518-23. doi: 10.1136/thx.54.6.518. Thorax. 1999. PMID: 10335006 Free PMC article.
-
Leukotriene receptor antagonists in children with cystic fibrosis lung disease : anti-inflammatory and clinical effects.Paediatr Drugs. 2005;7(6):353-63. doi: 10.2165/00148581-200507060-00004. Paediatr Drugs. 2005. PMID: 16356023 Review.
Cited by
-
The role of respiratory viruses in cystic fibrosis.J Cyst Fibros. 2008 Jul;7(4):320-328. doi: 10.1016/j.jcf.2007.12.002. Epub 2008 Feb 6. J Cyst Fibros. 2008. PMID: 18255355 Free PMC article.
-
Association between early respiratory viral infections and structural lung disease in infants with cystic fibrosis.J Cyst Fibros. 2022 Nov;21(6):1020-1026. doi: 10.1016/j.jcf.2022.04.014. Epub 2022 May 4. J Cyst Fibros. 2022. PMID: 35523715 Free PMC article.
-
Changes in rhinovirus protein 2C allow efficient replication in mouse cells.J Virol. 2003 Apr;77(8):4773-80. doi: 10.1128/jvi.77.8.4773-4780.2003. J Virol. 2003. PMID: 12663784 Free PMC article.
-
Pharmacokinetics and diffusion into sputum of oseltamivir and oseltamivir carboxylate in adults with cystic fibrosis.Antimicrob Agents Chemother. 2011 Sep;55(9):4183-7. doi: 10.1128/AAC.00371-11. Epub 2011 Jun 13. Antimicrob Agents Chemother. 2011. PMID: 21670188 Free PMC article. Clinical Trial.
-
Palivizumab, pneumococcal and influenza vaccination in cystic fibrosis.J R Soc Med. 2009 Jul;102 Suppl 1(Suppl 1):23-8. doi: 10.1258/jrsm.2009.s19006. J R Soc Med. 2009. PMID: 19605871 Free PMC article. No abstract available.
References
-
- Petersen NT, Hoiby N, Mordhorst CH, Lind K, Flensborg EW, Bruun B. Respiratory infections in cystic fibrosis patients caused by virus, chlamydia, and mycoplasma-possible synergism with Pseudomonas aeruginosa. Acta Paediatr Scand. 1981;70:623–628. - PubMed
-
- Wright PF, Oxman MT, Shwachman H. Evaluation of the safety of amantadine·HCl and the role of respiratory viral infections in children with cystic fibrosis. J Infect Dis. 1976;134:144–149. - PubMed
-
- Wang EEL, Prober CG, Manson B, Corey M, Levison H. Association of respiratory viral infections with pulmonary deterioration in patients with cystic fibrosis. N Engl J Med. 1984;311:1653–1658. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials